Map Pharmaceuticals Inc. has a market cap of $459.6 million; its shares were traded at around $15.11 with and P/S ratio of 8.5.
This is the insider trade history vs. stock price of MAPP. For the complete insider trading history of MAPP, click here.
Directors and Officers Recent Trades:
- SVP, Cor & Business Dev Anastasios Gianakakos sold 1,500 shares of MAPP stock on 08/01/2011 at the average price of 15.26. Anastasios Gianakakos owns at least 9,316 shares after this. The price of the stock has decreased by 0.98% since.
- SVP, Cor & Business Dev Anastasios Gianakakos sold 1,500 shares of MAPP stock on 07/01/2011 at the average price of 15.96. Anastasios Gianakakos owns at least 9,316 shares after this. The price of the stock has decreased by 5.33% since.
- SVP, Cor & Business Dev Anastasios Gianakakos sold 1,500 shares of MAPP stock on 06/01/2011 at the average price of 16.97. Anastasios Gianakakos owns at least 9,316 shares after this. The price of the stock has decreased by 10.96% since.
- SVP, Cor & Business Dev Anastasios Gianakakos sold 5,000 shares of MAPP stock on 05/09/2011 at the average price of 17. Anastasios Gianakakos owns at least 9,316 shares after this. The price of the stock has decreased by 11.12% since.
- SVP, Cor & Business Dev Anastasios Gianakakos sold 1,500 shares of MAPP stock on 05/02/2011 at the average price of 15.45. Anastasios Gianakakos owns at least 9,316 shares after this. The price of the stock has decreased by 2.2% since.
For the complete insider trading history of MAPP, click here.







